#Dicerna - Twitter Hashtag

Dirk Haussecker

@RNAiAnalyst

over 3 years ago

Novo Nordisk doubles down on #RNAi after #Dicerna acquisition: https://t.co/apBKfHat6g $arwr $alny #Novartis

0

8

1

0

3K

Dirk Haussecker

@RNAiAnalyst

about 4 years ago

So historically ocular-focused $PRQR did #RNAEditing deal with Eli Lilly which has experience in liver and CNS oligo delivery through its 2018 RNAi deal with #Dicerna. I'd say complementary + should accelerate ProQR's entry into those attractive tissues.

0

5

0

1

0

Evaluate Japan @EvaluateJP

almost 5 years ago

#Novo 社は、現金で33億ドルを投じて #Dicerna 社を #買収することで、RNA干渉関連ポートフォリオを手に入れた。それ以上に重要なのは、それらを支える技術であり、メタボリック対策の主力製品であるsemaglutideの先を見通すことが期待される。 https://t.co/BmjTf8XsRR #Evaluate

EvaluateJP's tweet photo. #Novo 社は、現金で33億ドルを投じて #Dicerna 社を #買収することで、RNA干渉関連ポートフォリオを手に入れた。それ以上に重要なのは、それらを支える技術であり、メタボリック対策の主力製品であるsemaglutideの先を見通すことが期待される。
https://t.co/BmjTf8XsRR
#Evaluate https://t.co/9rtcm7mgth

0

7

4

0

DER AKTIONÄR

@aktionaer

almost 5 years ago

#NovoNordisk: Hammer‑Deal mit #Dicerna – jetzt heben diese AKTIONÄR‑Tipps ab https://t.co/dEQjCDJgwC

0

1

0

Genia Turanova 🌻 @GTuranova

almost 5 years ago

Market prospects for #RNAi companies are boosted by today's M&A action: #NovoNordisk is buying #Dicerna with a price premium of 80%. This looks like a deal for Novo... who's been partners with Dicerna from 2019. $NVO $DRNA #biotech

GTuranova's tweet photo. Market prospects for #RNAi companies are boosted by today's M&A action: #NovoNordisk is buying #Dicerna with a price premium of 80%.

This looks like a deal for Novo... who's been partners with Dicerna from 2019.
$NVO $DRNA #biotech https://t.co/w7Q608c9yD

0

2

0

Evaluate Japan @EvaluateJP

about 5 years ago

今年初めに #α1アンチトリプシン欠損症（#AATD）で #Vertex 社のVX-864が失敗した後、#Arrowhead 社が注目すべき候補となったが、#Dicerna 社が発表したRNAi医薬品 #belcesiran の初期データによると、このプロジェクトも脚光を浴びる可能性が出てきた。 https://t.co/SAeZMovAYH #エバリュエート

EvaluateJP's tweet photo. 今年初めに #α1アンチトリプシン欠損症（#AATD）で #Vertex 社のVX-864が失敗した後、#Arrowhead 社が注目すべき候補となったが、#Dicerna 社が発表したRNAi医薬品 #belcesiran の初期データによると、このプロジェクトも脚光を浴びる可能性が出てきた。
https://t.co/SAeZMovAYH
#エバリュエート https://t.co/sNXV5SiE6O

0

3

2

0

Oligonucleotide Therapeutics Society @OTSociety

about 5 years ago

We want to thank Dicerna, one of our 2021 Virtual Conference Gold Level sponsors. Dicerna uses RNA interference to create medicines that silence or turn off the genes that cause or contribute to disease. Learn more on their website! https://t.co/fvwFpd7GZ1 #OTS #Dicerna

OTSociety's tweet photo. We want to thank Dicerna, one of our 2021 Virtual Conference Gold Level sponsors. Dicerna uses RNA interference to create medicines that silence or turn off the genes that cause or contribute to disease. Learn more on their website!

https://t.co/fvwFpd7GZ1

#OTS #Dicerna https://t.co/ckvQhtTimG

0

7

1

0

Scrip, Citeline Commercial @PharmaScrip

almost 6 years ago

The Licensing Deal of the Year goes to #Roche & #Dicerna for the siRNA RG6346 for Chronic #HepatitisB. Congratulations! #ScripAwards2020

PharmaScrip's tweet photo. The Licensing Deal of the Year goes to #Roche & #Dicerna for the siRNA RG6346 for Chronic #HepatitisB. Congratulations! #ScripAwards2020 https://t.co/OUaQ9Tevvi

0

5

0

Preticks @preticks

about 6 years ago

Latest headline: $DRNA: Dicerna Announces Positive Clinical Data for Investigational Treatments RG6346 for Chronic Hepatitis B Virus and Nedosiran for Primary Hyperoxaluria, and Presents Preclinical Data Applying RNAi Technology.. https://t.co/t7AZ79tRST #stockstowatch #Dicerna

0

3

1

0

malteseinvestor @malteseinvest

almost 7 years ago

Analysis: #NASDAQ $DRNA Case 72 #Dicerna Pharmaceuticals Inc DISCLAIMER: The analysis is strictly for educational purposes and should not be construed as an invitation to trade. Thread 👇👇👇 #DRNA 1/4

malteseinvest's tweet photo. Analysis: #NASDAQ $DRNA

Case 72 #Dicerna Pharmaceuticals Inc

DISCLAIMER: The analysis is strictly for educational purposes and should not be construed as an invitation to trade.

Thread 👇👇👇

#DRNA 1/4 https://t.co/23WdItSOnJ

1

4

0

Endpoints News

@endpts

almost 7 years ago

Roche signs up #Dicerna in a $200M-plus cash alliance to help develop a hep B cocktail, capping biotech's big year https://t.co/0yP3X2l73A $RHHBY

1

5

1

0

Oxalosis & Hyperoxaluria Foundation @OHFTweet

over 8 years ago

"Dicerna Pharmaceuticals has dosed the first patient with primary hyperoxaluria in Group B of a clinical trial of the investigational drug DCR-PHXC." This will be worth watching... #OHF #PrimaryHyperoxaluria #Dicerna #ClinicalTrial https://t.co/koNPZz1q2W

1

4

1

0